2011
Experience in international clinical research: the HIV Prevention Trials Network
Sista ND, Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH. Experience in international clinical research: the HIV Prevention Trials Network. Clinical Investigation 2011, 1: 1609-1618. PMID: 22348195, PMCID: PMC3281583, DOI: 10.4155/cli.11.156.Peer-Reviewed Original ResearchHIV Prevention Trials NetworkCombination antiretroviral therapyHIV transmissionClinical trialsPrevention strategiesTrials NetworkHPTN 052 studyOpiate agonist therapySerodiscordant sexual partnersHIV testing ratesPre-exposure prophylaxisHIV prevention strategiesPivotal efficacy trialsInjection drug usersHigh-risk behaviorsPublic health policyAgonist therapyAntiretroviral therapyHIV seroconversionInfected partnerMiddle-income countriesTrial feasibilityAntiretroviral drugsHPTN 068Efficacy trials
2001
Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study
Vermund SH. Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study. American Journal Of Epidemiology 2001, 153: 628-631. PMID: 11282788, DOI: 10.1093/aje/153.7.628.Peer-Reviewed Original Research
1994
NIH conference. HIV vaccine development: a progress report.
Hoth DF, Bolognesi DP, Corey L, Vermund SH. NIH conference. HIV vaccine development: a progress report. Annals Of Internal Medicine 1994, 121: 603-11. PMID: 8085693, DOI: 10.7326/0003-4819-121-8-199410150-00008.Peer-Reviewed Original ResearchConceptsVaccine candidatesAnimal modelsHuman immunodeficiency virus (HIV) infectionCytotoxic T cell responsesLarge-scale efficacy trialsInnovative vaccine candidatesImmunodeficiency virus infectionT cell responsesCorrelates of immunityEffective preventive vaccineProtective immune responseDiversity of HIVHIV vaccine researchHuman phase IPromising vaccine candidateUseful animal modelPreventive vaccineEfficacy trialsVirus infectionImmune responseVaccine researchSuch trialsPhase ITrialsHIVPrevention of HIV/AIDS with vaccines
Vermund S, Schultz A, Hoff R. Prevention of HIV/AIDS with vaccines. Current Opinion In Infectious Diseases 1994, 7: 82-94. DOI: 10.1097/00001432-199402000-00014.Peer-Reviewed Original ResearchHIV vaccineVaccine preparedness studyPhase II trialPhase III trialsHigh-risk populationHuman phase IViral envelope antigensHIV vaccine efficacyHigh behavioral riskLife-long infectionHIV/AIDSRecombinant subunit vaccinesEnvelope vaccinesHIV vaccinationII trialIII trialsClinical updateVaccine efficacyPreventive counselingEffective vaccineEfficacy trialsEnvelope antigenFirst vaccineTrial participantsLive vectorThe role of prevention research in HIV vaccine trials.
Vermund SH. The role of prevention research in HIV vaccine trials. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s303-5. PMID: 7865326.Peer-Reviewed Original ResearchConceptsVaccine trialsLarge-scale vaccine trialsHIV vaccine efficacy trialsPrevention researchVaccine efficacy trialsHIV vaccine trialsPrevention clinical trialsHIV prevention researchSexual transmissionClinical trialsEfficacy trialsNeedle useHIV researchInfectious diseasesBlood contaminationPotential trial sitesTrialsNational InstituteObservational researchTrial sitesSame criteriaPrevention technologiesAllergyVaccineInfection